원료의약품(API) 시장 : 제품 유형별, 분자 유형별, 제형별, 용도별, 지역별

Active Pharmaceutical Ingredients Market, By Product Type, By Molecular Type, By Formulation, By Application, By Geography

US $ 4,500 ￦ 6,354,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,884,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,120,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 원료의약품(API) 시장은 2023년에는 2,350억 달러에 달할 것으로 추정되며, 예측 기간(2023-2030년) CAGR은 6.8%에 달할 것으로 예측됩니다.

리포트 대상 범위		리포트 상세
기준년	2022년	2023년 시장 규모	2,350억 달러
실적 데이터	2018-2021년	예측 기간	2023-2030
예측 기간 CAGR	6.80%	2030년 시장 규모 예측	3,724억 달러

원료의약품(API)과 부형제는 의약품 제조에서 가장 중요한 두 가지 요소로, API는 의약품 제조에 사용되는 원료이며, 부형제는 정제에 함유된 유당, 미네랄 오일 등 의약품의 체내 흡수를 돕는 매개체 역할을 하는 물질입니다. 원료의약품은 연구개발 단계와 상업적 생산 단계 모두에서 첨단 기술을 이용한 산업 공정을 통해 생산됩니다. 다른 활동은 질병의 진단, 치료, 완화, 완화, 치료 및 예방에 약리학적 활성 및 기타 직접적인 영향을 미치거나 신체의 구조와 기능을 변화시키기 위해 개발됩니다. 원료의약품(API) 시장의 성장은 다양한 지역에서 정부의 자금 조달 구상 증가와 같은 특정 요인에 기인할 수 있습니다. 예를 들어 2020년 5월 미국 보건복지부(HHS)는 COVID-19 및 관련 질환 환자 치료를 위한 의약품에 필요한 원료의약품(API)을 생산하기 위해 제약회사 Phlow Corporation에 4년간 3억 5,400만 달러의 자금을 지원한다고 발표했습니다. 발표했습니다.

시장 역학

제약사들의 미국 식품의약국(FDA) 의약품 승인 증가는 예측 기간 중 세계 원료의약품(API) 시장의 성장을 더욱 촉진할 것으로 예상됩니다. 예를 들어 2020년 12월 미국 제약사 일라이 릴리(Eily Lilly)는 제2형 당뇨병 치료제 트루리시티(Trulicity) 증량, 전이성 사구체여과율(EGFR) 돌연변이 비소세포폐암 치료제 사이람자(Cyramza), 알츠하이머병 진단을 받은 사람에 대한 타우비드(tauvid) 등 여러 의약품에 대한 미국 미국 FDA의 승인을 획득했습니다.

본 조사의 주요 특징

• 세계의 원료의약품(API) 시장을 상세 분석하고, 2022년을 기준년으로 한 예측 기간(2023-2030년)의 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
• 다양한 부문의 잠재적 매출 기회를 설명하고, 이 시장에 대한 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 주요 인사이트도 제공하고 있습니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 기반하여 세계의 원료의약품(API) 시장의 주요 기업을 프로파일링하고 있습니다.
• 본 리포트로부터의 인사이트에 의해 마케팅 담당자 및 기업의 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 기반한 의사결정을 시행할 수 있습니다.
• 세계의 원료의약품(API) 시장 리포트는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참여업체, 재무 애널리스트 등 이 업계의 다양한 이해관계자에게 대응하고 있습니다.
• 이해관계자는 세계의 원료의약품(API) 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제

• 조사의 목적
• 가정
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 규제 시나리오
• 시장 동향
• API 특허 유효기간
• 생산능력 분석
• 합병, 인수, 협업 시나리오
• 주요 발전
• PEST 분석
• 투자와 자금조달
• 생산과 소비 분석

제4장 세계의 원료의약품(API) 시장 - COVID-19의 영향 분석

• 경제적 영향
• 신종 코로나바이러스 감염증(COVID-19) 역학
• 수요와 공급에 대한 영향

제5장 세계의 원료의약품(API) 시장, 제품 유형별, 2018-2030년

• 저효력 API
• 고효력 API

제6장 세계의 원료의약품(API) 시장, 분자 유형별, 2018-2030년

• 저분자
• 고분자

제7장 세계의 원료의약품(API) 시장, 제형별, 2018-2030년

• 경구
• 외용
• 주사
• 적하

제8장 세계의 원료의약품(API) 시장, 용도별, 2018-2030년

• 당뇨병
• 종양학
• 심장혈관
• 중추신경계
• 진통제
• 안과
• 호흡기
• 피부과
• 기타

제9장 세계의 원료의약품(API) 시장, 지역별, 2018-2030년

• 북미
• 미국
• 캐나다
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• ASEAN
• 호주
• 한국
• 기타 아시아태평양
• 중동
• GCC
• 이스라엘
• 기타 중동
• 아프리카
• 북아프리카
• 중앙아프리카
• 남아프리카

제10장 경쟁 구도

• 기업 개요
  • Teva Pharmaceutical Industries Ltd
  • Pfizer, Inc.
  • Dr. Reddy's Laboratories Ltd
  • Novartis AG
  • Mylan NV
  • Amneal Pharmaceuticals LLC
  • Lonza Group
  • Lupin Limited
  • Fresenius Kabi
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Endo International plc
  • Aurobindo Pharma Limited
  • Apotex Inc.
  • Taro Pharmaceutical Industries Ltd
  • Stada Arzneimittel AG
  • Krka Pharmaceuticals
  • CordenPharma International
  • Evonik Industries AG
  • Biological E. Limited

제11장 섹션

• 참고 문헌
• 조사 방법

KSA

영문 목차

영문목차

The global active pharmaceutical ingredients market is estimated to be valued at US$ 235 Billion in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 235 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.80%	2030 Value Projection:	US$ 372.4 Bn

Active pharmaceutical ingredients (APIs) and excipients are the two most important components in the production of a medication. API is the raw material that is used in manufacturing medications, whereas an excipient is a substance that functions as a medium to help the body absorb the drug, such as lactose or mineral oil in a tablet. Active pharmaceutical ingredients are produced by using highly technological industrial processes, both during the research and development and commercial production phases. Such compounds are developed to provide pharmacological activity or other direct impacts on disease diagnosis, cure, mitigation, therapy, or prevention, or to change the structure and function of the body. The growth of the active pharmaceutical ingredients (API) market can be attributed to certain factors, such as increasing funding initiatives by the government across different regions. For instance, in May 2020, the U.S. Department of Health and Human Services (HHS) announced that it will provide funding of US$ 354 million to Phlow Corporation, a pharmaceutical company, under a four-year contract to produce the active pharmaceutical ingredientss (APIs) needed for medications to treat patients with COVID-19 and related illnesses.

Market Dynamics

The rising U.S. Food and Drug Administration (FDA) approvals for drugs by pharmaceutical companies are further expected to boost the global active pharmaceutical ingredients (API) market growth during the forecast period. For instance, in December 2020, Eily Lilly, an American pharmaceutical company received U.S FDA clearance for several medicines, including increased dosages of its Trulicity therapy for the treatment of type 2 diabetes, Cyramza for the treatment of metastatic Estimated Glomerular Filteration Rate (EGFR)-mutated non-small cell lung cancer, and tauvid for individuals diagnosed with Alzheimer's disease.

Key features of the study:

• This report provides an in-depth analysis of the global active pharmaceutical ingredients (API) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global active pharmaceutical ingredients (API) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy's Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Endo International plc, Aurobindo Pharma Limited, Apotex Inc, Taro Pharmaceutical Industries Ltd, Stada Arzneimittel AG, Krka Pharmaceuticals, CordenPharma International, Evonik Industries AG, and Biological E. Limited.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global active pharmaceutical ingredients (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global active pharmaceutical ingredients (API) market.

Active Pharmaceutical Ingredients (API) Market Detailed Segmentation:

• By Product Type:
  • Low Potent APIs
  • High Potent APIs
• By Molecular Type:
  • Small Molecules
  • Large Molecules
• By Formulation:
  • Oral
  • Topical
  • Injectables
  • Drops
• By Application:
  • Diabetes
  • Oncology
  • Cardiovascular
  • CNS
  • Analgesics
  • Ophthalmic
  • Respiratory
  • Dermatology
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd
  • Pfizer, Inc.
  • Reddy's Laboratories Ltd
  • Novartis AG
  • Mylan N.V.
  • Amneal Pharmaceuticals LLC
  • Lonza Group
  • Lupin Limited
  • Fresenius Kabi
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Reddy's Laboratories Ltd
  • Endo International plc
  • Aurobindo Pharma Limited
  • Apotex Inc.
  • Taro Pharmaceutical Industries Ltd
  • Stada Arzneimittel AG
  • Krka Pharmaceuticals
  • CordenPharma International
  • Evonik Industries AG
  • Biological E. Limited

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Molecular Type
  • Market Snippet, By Formulation
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
• Impact Analysis
• Regulatory Scenario
• Market Trends
• API Patent Expiration
• Production Capability Analysis
• Mergers, Acquisitions and Collaboration Scenario
• Key Developments
• PEST Analysis
• Investments & Funding
• Production and Consumption Analysis

4. Global Active Pharmaceutical Ingredients (API) Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Active Pharmaceutical Ingredients (API) Market, By Product Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Low Potent APIs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• High Potent APIs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Active Pharmaceutical Ingredients (API) Market, By Molecular Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Small Molecules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Large Molecules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Injectables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• CNS
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Ophthalmic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Dermatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

9. Global Active Pharmaceutical Ingredients (API) Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Company Profiles
  • Teva Pharmaceutical Industries Ltd
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Pfizer, Inc.
  • Dr. Reddy's Laboratories Ltd
  • Novartis AG
  • Mylan N.V.
  • Amneal Pharmaceuticals LLC
  • Lonza Group
  • Lupin Limited
  • Fresenius Kabi
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Endo International plc
  • Aurobindo Pharma Limited
  • Apotex Inc.
  • Taro Pharmaceutical Industries Ltd
  • Stada Arzneimittel AG
  • Krka Pharmaceuticals
  • CordenPharma International
  • Evonik Industries AG
  • Biological E. Limited

11. Section

• References
• Research Methodology
• About us and Sales Contact

관련자료